Homepage

The Beauty Health Company

SKIN NASDAQ Categories PDF
Consumer Defensive · Household & Personal Products · United States · Updated May 10, 8:16pm
$0.58
Price
$75.2M
Market Cap
769
Employees
1.12
Beta
Pedro Malha
CEO
Business Description

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

Business History
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALC
Stock Price / EPS (Diluted)
-7.25
Stock Price: $0.58
EPS (Diluted): -0.08
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
2.88
Stock Price: $0.58
Total Equity: $61.10M
Shares: 135,798,202
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
5.87
Market Cap: $75.17M
Total Debt: $369.52M
Cash: $232.70M
EBITDA: $38.74M
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$321.7M
Market Cap: $75.17M
Total Debt: $369.52M
Cash: $232.70M
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
65.3%
Gross Profit: $196.36M
Revenue: $300.79M
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
-6.9%
Operating Income: -$20.80M
Revenue: $300.79M
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
-3.2%
Net Income: -$9.52M
Revenue: $300.79M
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
-9.4%
Net Income: -$9.52M
Total Equity: $61.10M
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
-2.5%
Operating Income: -$20.80M
Tax Rate: -60.3%
Equity: $61.10M
Total Debt: $369.52M
Cash: $232.70M
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
1.66
Current Assets: $309.50M
Current Liabilities: $186.30M
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
6.05
Short-Term Debt: $129.09M
Long-Term Debt: $240.43M
Total Debt: $369.52M
Total Equity: $61.10M
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$2.21
Revenue: $300.79M
Shares: 135,798,202
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$0.45
Total Equity: $61.10M
Shares: 135,798,202
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$0.27
Operating CF: $37.50M
CapEx: -$303,000
Shares: 135,798,202
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $0.58
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$9.52M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares SKIN against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
4h Dividend Discount Model — For dividend/income stocks only
4i Book Value Analysis — For deep value / turnaround stocks only
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Metric 2021 2022 2023 2024 2025
Revenue $260.1M $365.9M $398.0M $334.3M $300.8M
Cost of Revenue $81.5M $117.1M $242.9M $152.0M $104.4M
Gross Profit $178.5M $248.8M $155.1M $182.3M $196.4M
Operating Expenses $218.5M $274.6M $286.0M $250.1M $217.2M
Operating Income -$39.9M -$25.8M -$130.9M -$67.8M -$20.8M
Net Income -$378.8M $44.2M -$100.1M -$29.1M -$9.5M
EBITDA -$350.9M $81.6M -$53.6M $10.3M $38.7M
EPS $-3.67 $0.30 $-0.76 $-0.23 $-0.08
EPS (Diluted) — — — — —
Balance Sheet (Annual)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $901.9M $568.2M $523.0M $370.1M $232.7M
Total Current Assets $1.0B $783.3M $698.3M $477.1M $309.5M
Total Assets $1.2B $1.0B $929.1M $685.7M $499.8M
Current Liabilities $76.4M $71.7M $115.0M $68.2M $186.3M
Long-Term Debt $729.9M $734.1M $738.4M $552.2M $240.4M
Total Liabilities $916.5M $836.0M $869.7M $633.9M $438.7M
Total Equity $302.3M $167.1M $59.4M $51.8M $61.1M
Retained Earnings -$418.7M -$378.8M -$478.9M -$508.0M -$517.5M
Cash Flow (Annual)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow -$28.4M -$106.6M $21.8M $16.1M $37.5M
Capital Expenditure -$15.6M -$17.4M -$13.0M -$6.8M $-303,000
Free Cash Flow -$44.0M -$124.0M $8.7M $9.3M $37.2M
Acquisitions (net) -$22.9M -$1.5M -$18.5M $0 $0
Debt Repayment — — — — —
Dividends Paid — — — — —
Stock Buybacks $0 -$160.0M -$32.4M -$2.0M $0
Net Change in Cash $892.4M -$333.7M -$45.2M -$153.0M -$137.4M
Analyst Estimates (Annual)
Metric 2025 2026 2027 2028
Revenue $296.8M
$295.6M – $297.8M
 $290.6M
$289.0M – $292.0M
 $305.1M
$301.1M – $309.3M
 $315.9M
$312.8M – $318.9M
EBITDA -$44.6M
-$44.8M – -$44.5M
 -$43.7M
-$43.9M – -$43.5M
 -$45.9M
-$46.5M – -$45.3M
 -$47.5M
-$48.0M – -$47.0M
Net Income -$9.5M
-$11.0M – -$7.3M
 -$21.3M
-$35.6M – $1.1M
 -$5.8M
-$14.3M – $2.7M
 -$13.3M
-$15.0M – -$11.7M
EPS — — — —
Growth Trends (YoY %)
Metric 2022 2023 2024 2025
Revenue Growth +40.7% +8.8% -16.0% -10.0%
Gross Profit Growth +39.3% -37.7% +17.5% +7.7%
Operating Income Growth +35.3% -406.6% +48.2% +69.3%
Net Income Growth +111.7% -326.4% +70.9% +67.3%
EBITDA Growth +123.3% -165.6% +119.3% +274.7%
Insider Trading (Recent)
Date Insider Type Shares Price Value
2026-04-17 BEATTIE EDWARD SCOTT 0.00 $0.00 $0
2026-04-17 Shridharani Sachin Mahavir 0.00 $0.00 $0
2026-04-17 Tripp Kenneth Robert 0.00 $0.00 $0
2026-04-09 Lewis Sheri F-InKind 24,904.00 $0.92 $22,912
2026-04-09 MONAHAN MICHAEL P. F-InKind 26,776.00 $0.92 $24,634
2026-03-20 Malha Pedro Bruno Ferreira A-Award 2,654,867.00 $0.00 $0
2026-03-20 MONAHAN MICHAEL P. A-Award 746,681.00 $0.00 $0
2026-03-20 Menezes Ronald A-Award 746,681.00 $0.00 $0
2026-03-20 Lewis Sheri A-Award 746,681.00 $0.00 $0
2026-03-17 Lewis Sheri F-InKind 51,883.00 $1.17 $60,703
2026-03-17 Menezes Ronald F-InKind 61,471.00 $1.17 $71,921
2026-03-17 MONAHAN MICHAEL P. F-InKind 58,573.00 $1.17 $68,530
2025-11-13 SCHAISON PHILIPPE A-Award 57,692.00 $0.00 $0
2025-11-01 Menezes Ronald F-InKind 46,426.00 $1.43 $66,389
2025-10-30 SCHAISON PHILIPPE 0.00 $0.00 $0
2025-10-09 Malha Pedro Bruno Ferreira A-Award 961,538.00 $1.56 $1.5M
2025-10-09 Malha Pedro Bruno Ferreira A-Award 1,228,846.00 $1.56 $1.9M
2025-10-01 Malha Pedro Bruno Ferreira 0.00 $0.00 $0
2025-08-10 MONAHAN MICHAEL P. F-InKind 32,357.00 $1.89 $61,155
2025-06-16 Gruber Desiree A-Award 73,051.00 $0.00 $0
Community AI Feedback
Sign in to Contribute
No community reviews yet for SKIN. Be the first — export the analysis to your AI and contribute back.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.193 · 1946f027 · 2026-05-08 18:57:27